The University of Melbourne and Monash University are collaborating to launch M2 Venture Catalyst, a $80 million project that plans to commercialise their biomedical research. This venture is expected to work with hospitals, medical research institutes and commercial organisations to support new companies, increase investment and exports, create jobs in the sector and enable the fast-tracking of the development of new medicines to market. Previously commercialisation of such research has often been going offshore.